Susan Abu-Absi
Chief Operating Officer · Aura Biosciences, Inc.
- 2026
- Sep 1, 2026
- 1
Summary
Latest filing:
Susan Abu-Absi is Chief Operating Officer of Aura Biosciences, Inc. (AURA). 1 SEC Form 4 filing on record, dated 1 September 2026.
Recent transactions
1The latest SEC Form 4 transaction reported by Susan Abu-Absi.
Trading pattern
InsiderAlpha's records for Susan Abu-Absi go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Susan Abu-Absi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matrix Capital Management Company, LP - $39.04M in AURA purchases and sales in the last 12 months
- Los Pinos Elisabet de - $323K in AURA purchases and sales in the last 12 months
- Janet Jill Hopkins - $196K in AURA purchases and sales in the last 12 months
- Conor Kilroy - $143K in AURA purchases and sales in the last 12 months
- Anthony S. Gibney - $82K in AURA purchases and sales in the last 12 months
- Mark Plavsic - $80K in AURA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Susan Abu-Absi?
Susan Abu-Absi is a corporate insider, tracked as Chief Operating Officer of Aura Biosciences, Inc. (AURA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Susan Abu-Absi submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.